Institutional shares held 28.8 Million
15.7K calls
0 puts
Total value of holdings $155M
$84K calls
$0 puts
Market Cap $169M
31,368,500 Shares Out.
Institutional ownership 91.77%
# of Institutions 107


Latest Institutional Activity in TRDA

Top Purchases

Q2 2025
Royce & Associates LP Shares Held: 223K ($1.2M)
Q2 2025
Millennium Management LLC Shares Held: 170K ($916K)
Q2 2025
Qube Research & Technologies LTD Shares Held: 134K ($719K)
Q2 2025
Dimensional Fund Advisors LP Shares Held: 424K ($2.28M)
Q2 2025
Morgan Stanley Shares Held: 163K ($877K)

Top Sells

Q2 2025
Janus Henderson Group PLC Shares Held: 1.52M ($8.18M)
Q2 2025
Price T Rowe Associates Inc Shares Held: 2.57M ($13.8M)
Q2 2025
5 Am Venture Management, LLC Shares Held: 4.31M ($23.2M)
Q2 2025
Lazard Asset Management LLC Shares Held: 1.26K ($6.76K)
Q2 2025
Ubs Group Ag Shares Held: 24.8K ($133K)

About TRDA

Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1. It also engages in the development of EEV-PMO-CAG for the treatment of myotonic dystrophy type 1. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.


Insider Transactions at TRDA

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
303K Shares
From 5 Insiders
Grant, award, or other acquisition 280K shares
Exercise of conversion of derivative security 23.1K shares
Sell / Disposition
506K Shares
From 11 Insiders
Payment of exercise price or tax liability 47.8K shares
Open market or private sale 458K shares

Track Institutional and Insider Activities on TRDA

Follow Entrada Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TRDA shares.

Notify only if

Insider Trading

Get notified when an Entrada Therapeutics, Inc. insider buys or sells TRDA shares.

Notify only if

News

Receive news related to Entrada Therapeutics, Inc.

Track Activities on TRDA